Uniqure N V 's ROA from the first quarter of 2026 to the first quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Uniqure N V 's ROA in the first quarter of 2026?
Uniqure N V recorded a cumulative net loss of $-209 million during 12 months ending in the first quarter of 2026, resulting in a negative return on assets (ROA) of -27.15%.

However, within the Healthcare sector 402 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Mar 31 2026 quarter, so far to 3589, from total ROA ranking in the fourth quarter of 2025 at 4228.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Total Assets Change	24.78 %	64.33 %	41.9 %	-17.57 %	-19.21 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-209	-199	-235	-199	-218
Return On Assets (TTM)	-27.15 %	-27.21 %	-36.07 %	-34.01 %	-35.26 %
QURE's Total Ranking	# 3589	# 4228	# 3849	# 3840	# 3930
Total Assets (TTM) in million	764	810	905	598	612
Seq. Total Assets Change	-5.73 %	-10.48 %	51.47 %	-2.38 %	24.14 %
Seq. Net Income Change	-	-	-	-	-

QURE's 5 Years Annual ROA >> Back to QURE Management Effectiveness >> Compare QURE ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 151
Sector	# 403
Overall	# 3558

Return On Assets Statistics
High	Average	Low
66 %	-22.33 %	-46.88 %
(Jun 30 2021)		(Dec 31 2017)

Financial Statements
Uniqure N V 's Assets	$ 764 million	QURE's Balance sheet
Uniqure N V 's Income	$ -54 million	Quarterly QURE's Income Statement
QURE's Income by Division		See QURE's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	74.99 %	1.11 %	-33.89 %	-12.16 %	88.65 %
Total Assets in million	863	493	488	738	840
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-199	-240	-308	-127	330
Annual Return On Assets	-23.06 %	-48.58 %	-63.25 %	-17.19 %	39.25 %

QURE's 5 Years Annual ROA >> Back to QURE Management Effectiveness >> Compare QURE ROA to its Competitors

More Return On Assets Ratios
QURE's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
QURE's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for QURE's Competitors
Subscribers only: Roa for Uniqure N V 's Suppliers
Subscribers only: Return On Assets for QURE's Customers

You may also want to know
QURE's Roi	QURE's Inventory Turnover Ratio	QURE's Growth Rates	QURE's Dividend Comparisons
	QURE's Profitability Ratios	QURE's Asset Turnover Ratio	QURE's Dividend Growth
QURE's Roe	QURE's Valuation Ratios	QURE's Financial Strength Ratios	QURE's Dividend Payout Ratio

Companies with similar Return On Assets at Mar 31 2026, within Healthcare Sector

ROA

Date modified: 2026-09-26T07:30:32+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.